Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. - Wikidata - awgldk - TriplyDB

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.

http://www.wikidata.org/entity/Q33559608

about

The multi-biomarker approach for heart failure in patients with hypertension.Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.Systolic time intervals derived from electrocardiographic gated intra-renal artery Doppler waveform associated with left ventricular systolic function.Syndecans in heart fibrosis.Individualized prevention against hypertension based on Traditional Chinese Medicine Constitution Theory: A large community-based retrospective, STROBE-compliant study among Chinese population.Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis.An analysis of the types of recently published research in the field of cachexia.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.

P2860

Q35723466-98DE62C8-9284-4E2B-8BDA-91313B09E1B9 Q36664047-DF45183C-8C14-4370-8DF6-1CB62C27D13A Q37093167-CACED062-F03B-461B-AB40-6C0273B5E9EB Q37508213-8DA0740C-2675-4333-8114-C6DB283B1257 Q38615348-2516000B-DE7E-40F0-BECA-A690F7796078 Q38828613-078C1257-89B9-4225-AD6E-6233660A99AF Q38842278-25D00744-DAE2-45F8-AEA2-6E13C333BDD2 Q47183307-5A32190F-5A14-4C5E-BA9D-D90644B6FA92 Q47191844-2AE1720F-9216-4099-B20B-D45EE3030B89 Q47568983-98CD747C-6436-4ECB-9D7B-FFCB4598BD1F Q55610979-D67B31E9-1805-4DF0-A85B-FE68F6310F00

P2860

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.

http://www.wikidata.org/entity/Q33559608

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Biomarkers and echocardiograph ...... in patients with hypertension.

@ast

Biomarkers and echocardiograph ...... in patients with hypertension.

@en

Biomarkers and echocardiograph ...... in patients with hypertension.

@nl

type

label

Biomarkers and echocardiograph ...... in patients with hypertension.

@ast

Biomarkers and echocardiograph ...... in patients with hypertension.

@en

Biomarkers and echocardiograph ...... in patients with hypertension.

@nl

prefLabel

Biomarkers and echocardiograph ...... in patients with hypertension.

@ast

Biomarkers and echocardiograph ...... in patients with hypertension.

@en

Biomarkers and echocardiograph ...... in patients with hypertension.

@nl

P1433

Q33559608-DAD121EA-44C8-4C2F-B8B3-E1D2C70FDD81

P1476

Q33559608-C8DC6613-AC60-494F-AAFA-852DE215E0EE

P2093

Q33559608-2055D21F-0175-455F-85B9-8CF76FB19C61

Q33559608-39806921-8383-4424-AB99-B8AB778328AD

Q33559608-3F968BDD-9D65-4578-AEEC-5348B6713759

Q33559608-665383E9-D982-4622-BC28-5F080DD4E3CF

P2860

Q33559608-0175F386-E84C-4699-910E-9CA01BE6ED7D

Q33559608-1074F78D-BED9-4B29-B7FA-F404D2535157

Q33559608-24C71B32-833C-4D00-BA4F-A7E0D3809FBC

Q33559608-30D41941-A866-4D05-A970-EBDFDB7F83FA

Q33559608-3A6D13AE-914D-4A09-BA45-CA5A471B94AB

Q33559608-3BDD32E7-ABDC-44F7-80C2-6993656BABBD

Q33559608-42708436-9834-48C3-9BCA-662702A538CC

Q33559608-480729FC-CB1D-4155-BA1A-7E521CC67560

Q33559608-48C02315-056F-4ECD-A877-D05D21FEA7B6

Q33559608-59A7D486-FB0B-453B-BAEA-99889BA36F7A

P2888

Q33559608-4760E596-021B-4B84-92B4-3901E628053D

P304

Q33559608-60AE76A6-41E9-4FB8-B7C0-127F8284CE91

P31

Q33559608-A3300E75-0EA7-44F6-A585-27A91A1D4AAE

P356

Q33559608-16BE174D-72F8-45D9-B523-BD08D703BAC3

P407

Q33559608-E40C42C9-1656-4E31-B767-79B506B291BC

P478

Q33559608-D32E0FF8-25A3-4D76-ADBA-FC4B6052AFFD

P50

Q33559608-3CEBB71D-2C4E-46C9-8B63-EAD1F9661151

Q33559608-50B0A446-1DF5-4250-B73A-373A9A58BE14

Q33559608-B84DBAF1-AB77-4C59-8024-09752F8BD568

Q33559608-F5EB3147-4A89-4580-8B91-2F72996D32DD

P577

Q33559608-E1DEF7E6-16B1-43E4-A2CA-43106C37BFAB

P5875

Q33559608-F062BE4D-FC82-4A51-97C4-DF4AA78E8FA8

P6179

Q33559608-199F1E0E-0BC9-485F-88EB-5691A2FB3916

P698

Q33559608-822AB9BF-DDC8-4E2F-9ADE-B97239CB1583

P921

Q33559608-24CFD874-C46D-436C-975A-F770500C5D18

Q33559608-421FB013-71EF-4A45-BC13-4FFC04D7135B

Q33559608-B0820CA5-E8C4-4CAD-B471-9EDF622B266C

P932

Q33559608-C43F0739-91C6-44C3-AB80-D93E04953479

P356

P1433

Scientific Reports

P1476

Biomarkers and echocardiograph ...... in patients with hypertension.

@en

P2093

Anna Gluba

http://www.w3.org/2001/XMLSchema#string

Eva Gerdts

http://www.w3.org/2001/XMLSchema#string

Jacek Rysz

http://www.w3.org/2001/XMLSchema#string

Marta Michalska-Kasiczak

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study

Recommendations for chamber quantification.

Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community

What mechanisms underlie diastolic dysfunction in heart failure?

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

CaMK4 Gene Deletion Induces Hypertension.

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.

P2888

P304

8916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP08916

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stephan von Haehling

Agata Bielecka-Dabrowa

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273440945

http://www.w3.org/2001/XMLSchema#string

P6179

1019645713

http://www.w3.org/2001/XMLSchema#string

P698

25747153

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

arterial hypertension

P932

5390083

http://www.w3.org/2001/XMLSchema#string